Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pasithea Therapeutics Corp KTTA

Healthcare Biotechnology
Pasithea Therapeutics Corp. is a biotechnology company focused on the discovery, research and development of treatments for central nervous system (CNS) disorders and other diseases. The Company is advancing a pipeline of three therapeutic product candidates, with a focus on its lead product candidate, PAS-004, a macrocyclic mitogen-activated protein kinase, or MEK inhibitor. PAS-004 is a small... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KTTA)

Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers

GlobeNewswire 1 day ago

Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004

GlobeNewswire February 13, 2024

Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position

GlobeNewswire January 8, 2024

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

GlobeNewswire January 2, 2024

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

GlobeNewswire December 28, 2023

Pasithea Therapeutics Announces Results from 2023 Annual Meeting

GlobeNewswire December 19, 2023

Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models

GlobeNewswire December 11, 2023

Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders

GlobeNewswire November 29, 2023

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

GlobeNewswire November 29, 2023
View More News ››

Opinion & Analysis (NDAQ:KTTA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KTTA)

(KTTA) Trading Signals

JUST IN: $KTTA (KTTA) Trading Signals2024-02-15 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary...
whytestocks - February 15, 2024

KTTA ...early a.m runner on NR

and my 1st scalp of the day ....in at open & out at $2.31 Cheers !
Iseneschal - December 23, 2021

KTTA ....halted

should be back in 5 mins
Iseneschal - November 24, 2021

KTTA ..... This is what happens all the time

KTTA just announced a P.O  I knew it was there because of this: https://www.sec.gov/Archives/edgar/data/1841330/000121390021048419...
Iseneschal - November 24, 2021

KTTA - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - November 24, 2021

KTTA.....Sheesh....only 185 million shares traded today!

and the warrants traded 10 million up 200 % Let's just see what tomorrow brings shall we ?
Iseneschal - November 23, 2021
View more Bullboard ››

Safe Supply Streaming Co Ltd.

Safe Supply Streaming Co Ltd.

Safe Supply Streaming Co Ltd. is engaged in investing in the legal and regulated supply of drugs. The Company’s focus is ...
View More »